Differential impact of additional chromosomal abnormalities in myeloid vs lymphoid blast phase of chronic myelogenous leukemia in the era of tyrosine kinase inhibitor therapy

Z. Chen, J. E. Cortes, J. L. Jorgensen, W. Wang, C. C. Yin, M. J. You, E. Jabbour, H. M. Kantarjian, L. J. Medeiros, S. Hu

Research output: Contribution to journal › Letter › peer-review

21 Scopus citations

Fingerprint

Dive into the research topics of 'Differential impact of additional chromosomal abnormalities in myeloid vs lymphoid blast phase of chronic myelogenous leukemia in the era of tyrosine kinase inhibitor therapy'. Together they form a unique fingerprint.